Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Octane Biotech Inc. currently manages 4 pending office actions within the Chemistry & Materials technology area. The portfolio is distributed across 4 distinct examiners and 4 distinct art units, indicating a prosecution landscape where each pending matter is handled by a different individual in a different unit. This alignment between the number of actions, examiners, and art units suggests that no single examiner or unit holds a concentration of the company's active matters.
HENKEL, DANIELLE B is identified as the busiest examiner, though she is responsible for only 1 pending office action. This distribution means that the company must navigate the specific preferences and procedural tendencies of 4 different examiners simultaneously. Practitioners should prepare for varied feedback across these 4 distinct art units, as the lack of concentration prevents leveraging a single examiner's prior rulings or a specific unit's internal trends across multiple cases. The company's strategy must remain flexible to accommodate the diverse requirements of the 4 distinct examiners.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (25%) |
| Multi-statute (no §101) | 3 (75%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HENKEL, DANIELLE B | 1 | 56.2% | +23.6% |
| MUTREJA, JYOTI NAGPAUL | 1 | 81.0% | +4.0% |
| HASSAN, LIBAN M | 1 | 50.7% | +31.1% |
| SINES, BRIAN J | 1 | 80.1% | +5.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17635638 | PROCESS CONTROL SYSTEMS FOR AUTOMATED CELL ENGINEERING SYSTEMS | SINES, BRIAN J | 10d overdue |
| 18754402 | CELL CULTURE AND TISSUE ENGINEERING SYSTEMS WITH CONTROLLED ENVIRONMENTAL ZONES | HENKEL, DANIELLE B | — |
| 18354770 | CELL CULTURE CHAMBER FOR INCREASED CELL YIELD | MUTREJA, JYOTI NAGPAUL | — |
| 17751984 | END-TO-END CELL THERAPY AUTOMATION | HASSAN, LIBAN M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18754402 | CELL CULTURE AND TISSUE ENGINEERING SYSTEMS WITH CONTROLLED ENVIRONMENTAL ZONES | HENKEL, DANIELLE B | — |
| 17751984 | END-TO-END CELL THERAPY AUTOMATION | HASSAN, LIBAN M | — |
| Art Unit | Apps |
|---|---|
| 1799 | 1 |
| 1798 | 1 |
| 1636 | 1 |
| 1796 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18754402 | CELL CULTURE AND TISSUE ENGINEERING SYSTEMS WITH CONTROLLED ENVIRONMENTAL ZONES | HENKEL, DANIELLE B | 1799 | §102§103§112 | Non-Final OA | — | Pending | Jun 26, 2024 |
| 18354770 | CELL CULTURE CHAMBER FOR INCREASED CELL YIELD | MUTREJA, JYOTI NAGPAUL | 1798 | §102§103 | Non-Final OA | — | Pending | Jul 19, 2023 |
| 17751984 | END-TO-END CELL THERAPY AUTOMATION | HASSAN, LIBAN M | 1636 | §101§102§103§112 | Non-Final OA | — | Pending | May 24, 2022 |
| 17635638 | PROCESS CONTROL SYSTEMS FOR AUTOMATED CELL ENGINEERING SYSTEMS | SINES, BRIAN J | 1796 | §102§103 | Final Rejection | 10d overdue | Pending | Feb 15, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial